U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07251023) titled 'Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia' on Nov. 14.
Brief Summary: The goal of this clinical study is to learn if the study drug DMB-I (INN: Latrepirdine) works to treat Alzheimer type dementia in adults. It will also learn about the safety of DMB-I (INN: Latrepirdine).
The main questions it aims to answer are:
* Does DMB-I improve cognitive functions in patients with dementia associated with Alzheimer's disease, and how sigificant the improvement is?
* What medical problems do participants have when taking DMB-I? Researchers will compare DMB-I to a placebo (a look-alike substanc...